We are live on ! Find out more
BDSI

BioDelivery Sciences International, Inc.

Delisted

BDSI was delisted on the 22nd of March, 2022.

116 hedge funds and large institutions have $639M invested in BioDelivery Sciences International, Inc. in 2014 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 44 increasing their positions, 33 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more funds holding in top 10

Funds holding in top 10: 47 (+3)

58% more capital invested

Capital invested by funds: $403M → $639M (+$236M)

46% more call options, than puts

Call options by funds: $4.83M | Put options by funds: $3.31M

33% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 33

20% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 20

4% more funds holding

Funds holding: 112116 (+4)

Holders
116
Holders Change
+4
Holders Change %
+3.57%
% of All Funds
3.37%
Holding in Top 10
7
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+75%
% of All Funds
0.2%
New
24
Increased
44
Reduced
33
Closed
20
Calls
$4.83M
Puts
$3.31M
Net Calls
+$1.51M
Net Calls Change
-$9.59M
Name Holding Trade Value Shares
Change
Change in
Stake
SKK
51
Shepherd Kaplan Krochuk
Massachusetts
$1.59M -$774K -53,296 -36%
JP Morgan Chase
52
JP Morgan Chase
New York
$1.57M -$807K -55,625 -38%
SI
53
Shaker Investments
Ohio
$1.52M +$247K +17,000 +24%
CS
54
Credit Suisse
Switzerland
$1.52M -$1.09M -75,415 -46%
RSS
55
Rosenblum Silverman Sutton
California
$1.46M +$1.24M +85,300 New
Citadel Advisors
56
Citadel Advisors
Florida
$1.32M -$225K -15,473 -17%
California State Teachers Retirement System (CalSTRS)
57
California State Teachers Retirement System (CalSTRS)
California
$1.32M +$10.7K +739 +1%
Charles Schwab
58
Charles Schwab
California
$1.27M +$205K +14,119 +24%
LCG
59
Lisanti Capital Growth
New York
$1.23M +$1.05M +72,055 New
NFA
60
Nationwide Fund Advisors
Ohio
$1.17M +$277K +19,066 +39%
Deutsche Bank
61
Deutsche Bank
Germany
$1.15M +$649K +44,735 +197%
AQR Capital Management
62
AQR Capital Management
Connecticut
$1.12M +$132K +9,100 +16%
PPA
63
Parametric Portfolio Associates
Washington
$1.08M +$475K +32,721 +106%
TA
64
Teachers Advisors
New York
$1.06M
AllianceBernstein
65
AllianceBernstein
Tennessee
$1M +$367K +25,300 +76%
FAM
66
Fortaleza Asset Management
Illinois
$976K +$829K +57,090 New
PAM
67
Panagora Asset Management
Massachusetts
$946K -$310K -21,379 -28%
FSA
68
Franklin Street Advisors
North Carolina
$828K +$465K +32,025 +195%
EIM
69
Essex Investment Management
Massachusetts
$773K
Barclays
70
Barclays
United Kingdom
$708K +$594K +40,900 +5,271%
Janney Montgomery Scott
71
Janney Montgomery Scott
Pennsylvania
$704K +$61K +4,200 +11%
Susquehanna International Group
72
Susquehanna International Group
Pennsylvania
$695K -$522K -35,947 -47%
Morgan Stanley
73
Morgan Stanley
New York
$659K -$21.6K -1,487 -4%
MC
74
Menta Capital
California
$651K +$16K +1,100 +3%
NI
75
Numeric Investors
Massachusetts
$610K +$518K +35,700 New

BDSI Hedge Fund Activity: Q3 2014 in Review

116 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q3 2014, worth a combined $639M — up 58% from $403M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new BDSI positions and 20 closed out — a net gain of 4 holders — while 44 added to existing stakes and 33 trimmed.

The largest buyer was Invesco, adding an estimated $35M. The largest seller was Broadfin Capital, cutting an estimated $19.4M.

  • 116 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q3 2014, up from 112 in Q2 2014.
  • Funds reported $639M of BioDelivery Sciences International, Inc. stock for Q3 2014, up 58% quarter-over-quarter.
  • 24 funds opened new BioDelivery Sciences International, Inc. positions in Q3 2014 and 20 closed out, a net change of +4 holders.
  • The largest BioDelivery Sciences International, Inc. buyer in Q3 2014 was Invesco, an estimated $35M added.
  • The largest BioDelivery Sciences International, Inc. seller in Q3 2014 was Broadfin Capital, an estimated $19.4M sold.

Based on aggregated 13F filings for Q3 2014.